Monday, 09 Dec 2019

You are here

Top Rheumatology Centers Led by Johns Hopkins

Medscape has reported the results of the US News & World Report's annual ranking of the best adult rheumatology hospitals nationwide has again honored Johns Hopkins Hospital, with runner up status going to the Cleveland Clinic, Hospital for Special Surgery, NewYork-Presbyterian University of Columbia, and Cornell. 

These results are based on surveys of US rheumatology specialists responding to US News surveys.

Johns Hopkins was named by 42.2% of rheumatology specialists as being the best rheumtology center, just bating out the Cleveland Clinic (41.3%) and the Hospital for Special Surgery (34.7%)

The 2019 Top 14 Ranking of US rheumatology hospitals: 

  1. Johns Hopkins (42.2%)
  2. Cleveland Clinic (41.3%)
  3. Hospital for Special Surgery (34.7%)
  4. Mayo Clinic, Rochester, Minnesota (30.4%)
  5. Brigham and Women's Hospital, Boston, Massachusetts (21.4%)
  6. Massachusetts General Hospital, Boston (15.6%)
  7. UCSF Medical Center, San Francisco (15.1%)
  8. NYU Langone Hospitals, New York City (12.3%)
  9. UCLA Medical Center, Los Angeles (11.6%)
  10. University of Alabama at Birmingham Hospital (9.2%)
  11. Duke University Hospital, Durham, North Carolina (5.9%)
  12. University of Michigan Hospitals-Michigan Medicine, Ann Arbor (5.6%)
  13. MUSC Health-University Medical Center, Charleston, South Carolina (5.5%)
  14. Northwestern Memorial Hospital, Chicago, Illinois (5.0%)
Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Link Between Obstructive Lung Disease and Developing RA?

We all know that the microbiome in the gut may be very important for multiple immune diseases. However, new findings from the ACR, 2019 in Atlanta reinforce how important the interface is between the lungs and developing rheumatoid arthritis.

Smoking Cessation Lowers RA Disease Activity and CV Risks

A multinational cross-sectional cohort study suggests that smoking cessation in rheumatoid arthritis (RA) patients is associated with lower disease activity measures, improved lipid profiles and lower rates of cardiovascular (CV) events.

Apremilast Reduces Oral Ulcers in Behcet's Syndrome

A multinational trial finds a statistically significant number of patients with Behçet's syndrome showed a greater reduction in the number of oral ulcers with apremilast compared with placebo.

Systemic JIA-Associated Lung Disease

A disease you’ve never heard of is becoming increasingly common and carries a very poor prognosis. 

For me, one of most important aspects of attending the ACR Annual Meeting is to learn about conditions that I don’t know and that may afflict my patients when I return back home. This year’s meeting was no different.

Tapering Of Therapy In RA: Maybe Not So Aggressive Next Time

This ACR has seen some more great work on tapering of therapy in rheumatoid arthritis. It’s a hot topic and one which I get asked about all the time by my patients. Commonly when I start oral csDMARDs patients want to know how long they be will on therapy and that naturally leads to a discussion about what the plan will be in the future about tapering.